Joe Bress

Joe Bress is a Partner and Global Co-Head of Healthcare. He is based in Los Angeles.

Since joining Carlyle in 2007, Mr. Bress has been involved in investing and managing over $5 billion of equity investments in healthcare companies globally. He is currently a member of the boards of Acentra Health, Curia, CorroHealth, Launch Therapeutics, Millicent Pharma, Orsini Specialty Pharmacy, Saama Technologies, TriNetX, and WellDyneRx. He is also involved in Carlyle’s broader life sciences efforts, including the acquisition of Abingworth, as well as Carlyle’s investments in Included Health and Rede D’Or Sao Luiz. He was previously a member of the boards of Pharmaceutical Product Development (PPD), Visionary RCM, and X-Chem. Prior to Carlyle, Mr. Bress worked in the Mergers & Acquisitions group at UBS.

He received an MBA from Stanford University’s Graduate School of Business and an AB from Harvard College, where he graduated magna cum laude.